Min Kyung Ju

Min Kyung Ju

Auto-generated profile, based on publicly available information

Min Kyung Ju

Department of Molecular Biology, College of Natural Sciences, Pusan National University, Pusan 609-735, Republic of Korea

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2018 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
SLSu Yeon Lee
Su Yeon Lee
MJMin Kyung Ju
Min Kyung Ju
HJHyun Min Jeon
Hyun Min Jeon
EJEui Kyong Jeong
Eui Kyong Jeong
YLYig Ji Lee
Yig Ji Lee
HKHo Sung Kang
Ho Sung Kang
Rapidly growing malignant tumors frequently encounter hypoxia and nutrient (e.g., glucose) deprivation, which occurs because of insufficient blood supply. This results in necrotic cell death in the core region of solid tumors. Necrotic cells release their cellular cytoplasmic contents into the extracellular space, such as high mobility group box 1 (HMGB1), which is a nonhistone nuclear protein, but acts as a proinflammatory and tumor‐promoting cytokine when released by necrotic cells. These released molecules recruit immune and inflammatory cells, which exert tumor‐promoting activity by inducing angiogenesis, proliferation, and invasion. Development of a necrotic core in cancer patients is also associated with poor prognosis. Conventionally, necrosis has been thought of as an unregulated process, unlike programmed cell death processes like apoptosis and autophagy. Recently, necrosis has been recognized as a programmed cell death, encompassing processes such as oncosis, necroptosis, and others. Metabolic stress‐induced necrosis and its regulatory mechanisms have been poorly investigated until recently. Snail and Dlx‐2, EMT‐inducing transcription factors, are responsible for metabolic stress‐induced necrosis in tumors. Snail and Dlx‐2 contribute to tumor progression by promoting necrosis and inducing EMT and oncogenic metabolism. Oncogenic metabolism has been shown to play a role(s) in initiating necrosis. Here, we discuss the molecular mechanisms underlying metabolic stress‐induced programmed necrosis that promote tumor progression and aggressiveness.

1 January 2018 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
SLSu Yeon Lee
Su Yeon Lee
MJMin Kyung Ju
Min Kyung Ju
HJHyun Min Jeon
Hyun Min Jeon
YLYig Ji Lee
Yig Ji Lee
CKCho Hee Kim
Cho Hee Kim
HKHo Sung Kang
Ho Sung Kang
Metastasis is a major obstacle to the efficient and successful treatment of cancer. Initiation of metastasis requires epithelial‐mesenchymal transition (EMT) that is regulated by several transcription factors, including Snail and ZEB1/2. EMT is closely linked to the acquisition of cancer stem cell (CSC) properties and chemoresistance, which contribute to tumor malignancy. Tumor suppressor p53 inhibits EMT and metastasis by negatively regulating several EMT‐inducing transcription factors and regulatory molecules; thus, its inhibition is crucial in EMT, invasion, metastasis, and stemness. Metabolic alterations are another hallmark of cancer. Most cancer cells are more dependent on glycolysis than on mitochondrial oxidative phosphorylation for their energy production, even in the presence of oxygen. Cancer cells enhance other oncogenic metabolic pathways, such as glutamine metabolism, pentose phosphate pathway, and the synthesis of fatty acids and cholesterol. Metabolic reprogramming in cancer is regulated by the activation of oncogenes or loss of tumor suppressors that contribute to tumor progression. Oncogenic metabolism has been recently linked closely with the induction of EMT or CSC phenotypes by the induction of several metabolic enzyme genes. In addition, several transcription factors and molecules involved in EMT or CSCs, including Snail, Dlx‐2, HIF‐1α, STAT3, TGF‐β, Wnt, and Akt, regulate oncogenic metabolism. Moreover, p53 induces metabolic change by directly regulating several metabolic enzymes. The collective data indicate the importance of oncogenic metabolism in the regulation of EMT, cell invasion and metastasis, and adoption of the CSC phenotype, which all contribute to malignant transformation and tumor development. In this review, we highlight the oncogenic metabolism as a key regulator of EMT and CSC, which is related with tumor progression involving metastasis and chemoresistance. Targeting oncometabolism might be a promising strategy for the development of effective anticancer therapy.

18 May 2022 in EMBO Reports
Verified
Journal Article
Closed access
MJMin Kyung Ju
Min Kyung Ju
JLJoo Rak Lee
Joo Rak Lee
YCYeonsong Choi
Yeonsong Choi
SPSeon Young Park
Seon Young Park
HSHee Jung Sul
Hee Jung Sul
DZDae Young Zang
Dae Young Zang

30 August 2012 in Journal of Life Science
Verified
Journal Article
Closed access
SLSu-Yeon Lee
Su-Yeon Lee
HJHyun-Min Jeon
Hyun-Min Jeon
MJMin-Kyung Ju
Min-Kyung Ju
CKCho-Hee Kim
Cho-Hee Kim
EJEui-Kyong Jeong
Eui-Kyong Jeong
HKHo-Sung Kang
Ho-Sung Kang

30 August 2013 in Journal of Life Science
Verified
Journal Article
Closed access
HJHyun Min Jeon
Hyun Min Jeon
SLSu Yeon Lee
Su Yeon Lee
MJMin Kyung Ju
Min Kyung Ju
HPHye Gyeong Park
Hye Gyeong Park
HKHo Sung Kang
Ho Sung Kang

30 July 2011 in Journal of Life Science
Verified
Journal Article
Closed access
SLSu-Yeon Lee
Su-Yeon Lee
EJEui-Kyong Jeong
Eui-Kyong Jeong
HJHyun-Min Jeon
Hyun-Min Jeon
MJMin-Kyung Ju
Min-Kyung Ju
CKCho-Hee Kim
Cho-Hee Kim
HKHo-Sung Kang
Ho-Sung Kang